Get the Stockscreener App
0.00
100.00%
-2.27
After Hours:
2.25
2.25
+
Acelyrin Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Acelyrin Inc is a late-stage clinical biopharmaceutical company. The clinical biopharma segment researches and develops treatments for diseases with pathology related to excess activation of the immune system. It is focused on providing patients with life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of transformative medicines.
See More
Previous Close:
$2.27
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$227.15M
Revenue:
-
Net Income/Loss:
$-299.80M
P/E Ratio:
0.00
EPS:
-2.84
Net Cash Flow:
$-217.49M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$6.52
Acelyrin Inc Stock (SLRN) Company Profile
Name
Acelyrin Inc
Sector
Industry
Phone
805-456-4393
Address
4149 LIBERTY CANYON RD., AGOURA HILLS
Compare SLRN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SLRN
Acelyrin Inc
|
0.00 | 227.15M | 0 | -299.80M | -217.49M | -2.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Acelyrin Inc Stock (SLRN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-14-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-08-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-13-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-08-23 | Initiated | Citigroup | Neutral |
| Sep-13-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Sep-05-23 | Initiated | H.C. Wainwright | Buy |
| May-30-23 | Initiated | Jefferies | Buy |
| May-30-23 | Initiated | Morgan Stanley | Overweight |
| May-30-23 | Initiated | Piper Sandler | Overweight |
| May-30-23 | Initiated | TD Cowen | Outperform |
View All
Acelyrin Inc Stock (SLRN) Latest News
Real time alert setup for Acelyrin Inc. performanceDay Trade & Weekly Top Stock Performers List - newser.com
Can technical indicators confirm Acelyrin Inc.’s reversalDay Trade & Free Risk Controlled Daily Trade Plans - newser.com
What sentiment indicators say about Acelyrin Inc. stockJuly 2025 Short Interest & Accurate Buy Signal Alerts - newser.com
What candlestick patterns are forming on Acelyrin Inc.Rate Hike & Fast Entry Momentum Trade Alerts - newser.com
Does Acelyrin Inc. qualify in momentum factor screeningJuly 2025 Movers & Technical Pattern Based Buy Signals - newser.com
Using data models to predict Acelyrin Inc. stock movementRecession Risk & Weekly Chart Analysis and Guides - newser.com
Acelyrin stock drops as izokibep trial fails to meet primary endpoint - MSN
Will Acelyrin Inc. stock deliver consistent dividendsTrade Risk Report & Free Long-Term Investment Growth Plans - newser.com
How to manage a losing position in Acelyrin Inc.CEO Change & Fast Momentum Stock Entry Tips - newser.com
Is Acelyrin Inc a good long term investmentMonthly Performance Summary & Small Budget Big Profits - earlytimes.in
Published on: 2025-09-30 00:47:13 - newser.com
What analysts say about Acelyrin Inc stockHead and Shoulders Patterns & Affordable Portfolio Tips - earlytimes.in
Bull Bear: How cyclical is Acelyrin Incs revenue streamEarnings Miss & Weekly High Potential Stock Alerts - خودرو بانک
Retail Trends: Can Acelyrin Inc outperform under higher oil pricesEntry Point & Smart Money Movement Alerts - khodrobank.com
Can machine learning forecast Acelyrin Inc. recoveryPortfolio Return Report & Long-Term Growth Plans - newser.com
Can Acelyrin Inc. rally from current levelsEarnings Risk Summary & Weekly High Conviction Trade Ideas - newser.com
How to use a screener to detect Acelyrin Inc. breakoutsMarket Trend Report & Verified Stock Trade Ideas - newser.com
Can trapped investors hope for a rebound in Acelyrin Inc.Weekly Trade Summary & Weekly High Return Forecasts - newser.com
EADV: Affibody’s Izokibep Back On The HS Radar - insights.citeline.com
Will Acelyrin Inc. see short term momentumMarket Sentiment Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Aug Mood: Why is Acelyrin Inc stock going downPortfolio Update Report & Community Driven Trade Alerts - خودرو بانک
Income Plays: Is Acelyrin Incs ROE strong enough2025 Stock Rankings & Consistent Growth Equity Picks - خودرو بانک
IPO Launch: Will Disc Medicine Inc. benefit from rising consumer demandWatch List & Fast Entry and Exit Trade Plans - خودرو بانک
Aug Selloffs: Is Acelyrin Inc. a good ESG investmentAnalyst Downgrade & Fast Gain Stock Tips - خودرو بانک
Exit Recap: Whats the fair value of Acelyrin Inc stockGDP Growth & AI Enhanced Trade Execution Alerts - khodrobank.com
Volume Recap: Can Acelyrin Inc outperform under higher oil pricesJuly 2025 Weekly Recap & Consistent Profit Alerts - خودرو بانک
Aug Retail: Is Acelyrin Inc stock influenced by commodity prices2025 Key Highlights & Community Verified Watchlist Alerts - خودرو بانک
Trading Recap: Is Acelyrin Inc showing insider buyingBreakout Watch & Advanced Technical Signal Analysis - خودرو بانک
Travel Stocks: Is Acelyrin Inc.’s growth already priced inJuly 2025 Analyst Calls & Technical Pattern Based Buy Signals - خودرو بانک
Acelyrin Inc Stock (SLRN) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):